Cargando…
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
BACKGROUND: While tumor suppressor p53 functions primarily as a transcription factor in the nucleus, cellular stress can cause p53 to translocate to the mitochondria and directly trigger a rapid apoptotic response. We have previously shown that fusing p53 (or its DNA binding domain, DBD, alone) to t...
Autores principales: | Lu, Phong, Vander Mause, Erica R., Redd Bowman, Katherine E., Brown, Sarah M., Ahne, Lisa, Lim, Carol S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521536/ https://www.ncbi.nlm.nih.gov/pubmed/31092272 http://dx.doi.org/10.1186/s13048-019-0516-2 |
Ejemplares similares
-
p53-Bad* in a Hepatocellular Carcinoma Mouse Model
por: Bowman, Katherine Redd, et al.
Publicado: (2023) -
Variation in the Mechanical Unfolding Pathway of p53DBD Induced by Interaction with p53 N-Terminal Region or DNA
por: Taniguchi, Yukinori, et al.
Publicado: (2012) -
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer
por: Wallis, Bryce, et al.
Publicado: (2023) -
p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020) -
Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)